Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_246471553178f22aa9c82e89c58a42ae |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2800-782 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-37 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-4913 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-663 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-08 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-663 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-66 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-49 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-33 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q19-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q19-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 |
filingDate |
2008-12-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2015-09-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_42a4c80a03af043bc103736cc8d6bd00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8aaf2d655616c80ba232ab620e4d76c3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cd8e3ff4b7ada7b04573a3e78496dc1c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a7d5229b213b070104e31937df58ad4e |
publicationDate |
2015-09-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
ES-2546208-T3 |
titleOfInvention |
Cosmetic and / or dermatological composition comprising an HMG-CoA reductase inhibitor and a farnesyl pyrophosphate synthase inhibitor |
abstract |
Topical dermatological composition comprising: - at least one hydroxymethylglutaryl-coenzyme A (HMG-CoA) reductase inhibitor, and - at least one farnesyl pyrophosphate synthase inhibitor, for use in the treatment of selected skin and / or hair disorders among the group comprising pathological premature cutaneous aging and / or pathological premature myo-lipo-cutaneous aging. |
priorityDate |
2008-01-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |